Methyllycaconitine alleviates amyloid-β peptides-induced cytotoxicity in SH-SY5Y cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zheng, XiaoLei ^a   Xie, ZhaoHong ^a   Zhu, ZhengYu ^a   Liu, Zhen ^a   Wang, Yun ^a   Wei, LiFei ^a   Yang, Hui ^a   Yang, HongNa ^a   Liu, YiQing ^a   Bi, JianZhong ^a,b  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; MAMMALIAN TARGET OF RAPAMYCIN; METHYLLYCACONITINE; ACONITINE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT; TARGET OF RAPAMYCIN KINASE;

ARTICLE; AUTOPHAGY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NEUROTOXICITY; ANALOGS AND DERIVATIVES; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACONITINE; AMYLOID BETA-PEPTIDES; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84910018739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111536     Document Type: Article

References (48)

1. Mancuso M, Orsucci D, LoGerfo A, Calsolaro V, Siciliano G (2010) Clinical features and pathogenesis of Alzheimer's disease: Involvement of mitochondria and mitochondrial DNA. Adv Exp Med Biol 685: 34-44. PubMed: 20687493.
2. Förstl H, Kurz A (1999) Clinical features of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 249: 288-290. PubMed: 10653284.
3. Cumming T, Brodtmann A (2010) Dementia and stroke: The present and future epidemic. Int J Stroke 5: 453-454. doi: 10.1111/j.1747-4949.2010.00527.x. PubMed: 21050400.
4. Buckingham SD, Jones AK, Brown LA, Sattelle DB (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61: 39-61. doi: 10.1124/pr.108.000562. PubMed: 19293145.
5. Perl DE (2010) Neuropathology of Alzheimer's disease. Mt Sinai J Med 77: 32-42. doi: 10.1002/msj.20157. PubMed: 20101720.
6. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148: 1204-1222. doi: 10.1016/j.cell.2012.02.040. PubMed: 22424230.
7. Sinha S, Lieberburg I (1999) Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci USA 96: 11049-11053. PubMed: 10500121.
8. Murphy MP, LeVine H 3rd (2010) Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 19: 311-23. doi: 10.3233/JAD-2010-1221. PubMed: 20061647.
9. Frozza RL, Horn AP, Hoppe JB, Simão F, Gerhardt D et al. (2009) A comparative study of beta-amyloid peptides Abeta1-42 and Abeta25-35 toxicity in organotypic hippocampal slice cultures. Neurochem Res 34: 295-303. doi: 10.1007/s11064-008-9776-8. PubMed: 18686032.
10. Selkoe DJ (1994) Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53: 438-447. PubMed: 8083687.
11. Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221: 3-12. doi: 10.1002/path.2697. PubMed: 20225336.
12. Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol 8: 931-937. PubMed: 17712358.
13. Yang Z, Klionsky DJ (2009) An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 335:1-32. doi: 10.1007/978-3-642-00302-8-1. PubMed: 19802558.
14. Kim J, Kundu M, Viollet B, Guan KL (2011) AMPKand mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology 13(2):132-41. doi: 10.1038/ncb2152. PubMed: 21258367.
15. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C et al. (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64: 113-122. PubMed: 15751225.
16. Shacka JJ, Roth KA, Zhang J (2008) The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy. Front Biosci 13: 718-736. PubMed: 17981582.
17. Ling D, Salvaterra PM (2011) Brain aging and Aβ1-42 neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging. Acta Neuropathol 121: 183-191. doi: 10.1007/s00401-010-0772-0. PubMed: 21076961.
18. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61: 75-111. PubMed: 10759066.
19. Nordberg A (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49: 200-210. PubMed: 11230871.
20. Jiang H, Liu CX, Feng JB, Wang P, Zhao CP et al. (2010) Granulocyte colony-stimulating factor attenuates chronic neuroinflammation in the brain of amyloid precursor protein transgenic mice: an Alzheimer's disease mouse model. J Int Med Res 38: 1305-1312. PubMed: 20926003.
21. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP et al. (2000) beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275: 5626-5632. PubMed: 10681545.
22. Alkondon M, Pereira EF, Wonnacott S, Albuquerque EX (1992) Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 41: 802-808. PubMed: 1569927.
23. Thomsen MS, Mikkelsen JD (2012) The a 7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia. J Neuroimmunol 251: 65-72. doi: 10.1016/j.jneuroim.2012.07.006. PubMed: 22884467.
24. Hansen SB, Sulzenbacher G, Huxford T, Marchot P, Taylor P et al. (2005) Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J 24: 3635-3646. PubMed: 16193063.
25. Liu RT1, Zou LB, Lü QJ (2009) Liquiritigenin inhibits Abeta(25-35)-induced neurotoxicity and secretion of Abeta(1-40) in rat hippocampal neurons. Acta Pharmacol Sin 30(7):899-906. doi: 10.1038/aps.2009.74.
26. Luo S, Lan T, Liao W, Zhao M, Yang H (2012) Genistein inhibits Aβ25 - 35-induced neurotoxicity in PC12 cells via PKC signaling pathway. Neurochem Res 37: 2787-2794. doi: 10.1007/s11064-012-0872-4. PubMed: 22949092.
27. Cho HJ, Son SM, Jin SM, Hong HS, Shin DH et al. (2009) RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. FASEB J 23: 2639-2649. doi: 10.1096/fj.08-126383. PubMed: 19332646.
28. Puttfarcken PS, Manelli AM, Neilly J, Frail DE (1996) Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells. Exp Neurol 138: 73-81. PubMed: 8593898.
29. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-termpotentiation in vivo. Nature 416: 535-539. PubMed: 11932745.
30. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842. doi: 10.1038/nm1782. PubMed: 18568035.
31. Son SM, Jung ES, Shin HJ, Byun J, Mook-Jung I (2012) Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKK β-AMPK signaling. Neurobiology of Aging 33: 1006.e11-e23. doi: 10.1016/j.neurobiolaging.2011.09.039. PubMed: 22048125.
32. Mizushima N (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36: 2491-502. PubMed: 15325587.
33. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL et al. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245-4249. PubMed: 3159021.
34. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ et al. (1999) Soluble pool of Ab amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866. PubMed: 10589538.
35. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866. PubMed: 10589538.
36. Citron M (2004) Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 5: 677-85. PubMed: 15322526.
37. Navarro HA, Zhong D, Abraham P, Xu H, Carroll FI (2000) Synthesis and pharmacological characterization of [125I] iodomethyllycaconitine ([125I] Iodo-MLA). A new ligand for the α7 nicotinic acetylcholine receptor. Journal of medicinal chemistry 43, 142-145. PubMed: 10649969.
38. Lockman PR, Van der Schyf CJ, Abbruscato TJ, Allen DD (2005) Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. J Neurochem 2005 Jul;94(1):37-44. DOI: 10.1111/j.1471-4159.2005.03162.x. PubMed: 15953347.
39. Funderburk SF, Marcellino BK, Yue Z (2010) Cell "self-eating" (autophagy) mechanism in Alzheimer's disease. MtSinai J Med 77: 59-68. doi: 10.1002/msj.20161. PubMed: 20101724.
40. Yang S, Wang S, Peng N, Xie Z, Wang P et al. (2012) Butyrolactone derivative 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one protects against amyloid-β peptides-induced cytotoxicity in PC12 cells. J Alzheimers Dis 28: 345-356. doi: 10.3233/JAD-2011-110863. PubMed: 21988929.
41. Barnett A, Brewer GJ (2011) Autophagy in aging and Alzheimer's disease: pathologic or protective? J Alzheimers Dis 25: 85-94. doi: 10.3233/JAD-2011-101989. PubMed: 21422527.
42. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R et al. (2008) The autophagy-related protein beclin1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118: 2190-2199. doi: 10.1172/JCI33585. PubMed: 18497889.
43. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O et al. (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979. doi: 10.1371/journal.pone.0009979. PubMed: 20376313.
44. Wang H, Ma J, Tan Y, Wang Z, Sheng C et al. (2010) Amyloid-beta1 - 42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells. J Alzheimers Dis 21: 597-610. doi: 10.3233/JAD-2010-091207. PubMed: 20571221.
45. Maycotte P, Guemez-Gamboa A, Moran J (2010) Apoptosis and autophagy in rat cerebellar granule neuron death: Role of reactive oxygen species. J Neurosci Res 88: 73-85. doi: 10.1002/jnr.22168. PubMed: 19598251.
46. Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM (2009) Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4: e4201. doi: 10.1371/journal.pone.0004201. PubMed: 19145255.
47. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD et al. (2005) Macroautophagy - a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171: 87-98. PubMed: 16203860.
48. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF et al. (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA 107: 14164-14169. doi: 10.1073/pnas.1009485107. PubMed: 20660724.